soman has been researched along with Acute Brain Injuries in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Rossetti, K | 1 |
| He, H; Lin, G; Long, J; Luo, Y; Sui, X; Wang, Q; Wang, S; Wang, Y; Yang, J | 1 |
| Kuruba, R; Reddy, DS; Wu, X; Zaayman, M | 1 |
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; De Araujo Furtado, M; Figueiredo, TH | 1 |
| Barbier, L; Beaup, C; Canini, F; Denis, J; Dorandeu, F; Foquin, A; Giroud, C; Maury, R; Peinnequin, A | 1 |
| Baille, V; Campo, P; Carpentier, P; Dorandeu, F; Foquin, A; Job, A; Pouyatos, B | 1 |
| Chen, C; Hu, XZ; Jacobowitz, DM; Lyman, M; Marini, AM; McDonough, J; Pan, H; Van Shura, K | 1 |
| Aas, P; Enger, S; Myhrer, T | 1 |
8 other study(ies) available for soman and Acute Brain Injuries
| Article | Year |
|---|---|
Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.
Topics: Animals; Anticonvulsants; Brain; Brain Injuries; Female; Male; Midazolam; Nerve Agents; Rats; Seizures; Soman; Status Epilepticus | 2023 |
TRPV4 Regulates Soman-Induced Status Epilepticus and Secondary Brain Injury via NMDA Receptor and NLRP3 Inflammasome.
Topics: Animals; Brain; Brain Injuries; Inflammasomes; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Receptors, N-Methyl-D-Aspartate; Soman; Status Epilepticus; TRPV Cation Channels | 2021 |
Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman.
Topics: Animals; Anticonvulsants; Brain; Brain Injuries; Diazepam; Hippocampus; Isoflurophate; Male; Neurons; Organophosphates; Pilocarpine; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus | 2021 |
Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats.
Topics: Animals; Anticonvulsants; Body Weight; Brain Injuries; Brain Waves; Cholinesterase Inhibitors; Cyclopentanes; Disease Models, Animal; Drug Therapy, Combination; Electroencephalography; Fluoresceins; Fourier Analysis; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Seizures; Soman; Tetrazoles; Time Factors | 2018 |
Beneficial effects of a ketamine/atropine combination in soman-poisoned rats under a neutral thermal environment.
Topics: Animals; Anticonvulsants; Atropine; Body Temperature; Brain; Brain Injuries; Chemical Warfare Agents; Cholinesterases; Corticosterone; Disease Models, Animal; Drug Therapy, Combination; Epilepsy; Fever; Gene Expression Regulation; Ketamine; Male; Motor Activity; Rats; Rats, Wistar; Ribosomal Proteins; Soman; Time Factors | 2015 |
Prediction of soman-induced cerebral damage by distortion product otoacoustic emissions.
Topics: Animals; Brain Injuries; Cochlea; Forecasting; Male; Neuroprotective Agents; Otoacoustic Emissions, Spontaneous; Random Allocation; Rats; Rats, Wistar; Seizures; Soman | 2010 |
Alpha-linolenic acid is a potent neuroprotective agent against soman-induced neuropathology.
Topics: alpha-Linolenic Acid; Analysis of Variance; Animals; Brain Injuries; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Electrophoretic Mobility Shift Assay; Fluoresceins; Male; Nerve Degeneration; Neuroprotective Agents; Neurotoxicity Syndromes; NF-kappa B; Organic Chemicals; Rats; Rats, Sprague-Dawley; Soman | 2012 |
Anticonvulsant effects of damage to structures involved in seizure induction in rats exposed to soman.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Weight; Brain; Brain Injuries; Disease Models, Animal; Male; Rats; Rats, Wistar; Reaction Time; Seizures; Soman; Time Factors | 2007 |